Company · CIK 0001937993 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Cadrenal Therapeutics, Inc. · CVKD
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 29, 2026 SForm 4 → | Jul 1, 9:52 pm EDT | Quang X PhamChairman and CEO, Director, 10% Owner | 7,400 | $3.03 | $22,422 | 98,589 | −6.98% | 10b5-1 |
| Jun 25, 2026 SForm 4 → | Jun 26, 8:44 pm EDT | Quang X PhamChairman, CEO and Interim CFO, Director, 10% Owner | 11,156 | $3.04 | $33,919 | 105,989 | −9.52% | 10b5-1 |
| Jun 22, 2026 SForm 4 → | Jun 24, 5:15 pm EDT | Quang X PhamChairman, CEO and Interim CFO, Director, 10% Owner | 11,444 | $3.48 | $39,829 | 117,145 | −8.90% | 10b5-1 |
| Jun 16, 2026 SForm 4 → | Jun 18, 6:36 pm EDT | Quang X PhamChairman, CEO and Interim CFO, Director, 10% Owner | 4,126 | $3.18 | $13,110 | 128,589 | −3.11% | 10b5-1 |
| Jun 11, 2026 SForm 4 → | Jun 15, 8:58 pm EDT | Quang X PhamChairman, CEO and Interim CFO, Director, 10% Owner | 18,124 | $3.88 | $70,352 | 132,715 | −12.0% | |
| Jun 8, 2026 SForm 4 → | Jun 10, 8:26 pm EDT | Quang X PhamChairman, CEO and Interim CFO, Director, 10% Owner | 22,385 | $4.17 | $93,294 | 150,839 | −12.9% | 10b5-1 |
| Jun 3, 2026 SForm 4 → | Jun 5, 5:26 pm EDT | Quang X PhamCEO and Chairman, Director, 10% Owner | 8,285 | $4.37 | $36,209 | 173,224 | −4.56% | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.